Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Cell Reports|August 9, 2016
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AMLYue Zhao, Qi Liu, Pankaj Acharya, et al.
Haematologica|January 22, 2026
Imetelstat improves patient-reported outcomes and quality of life in lower-risk myelodysplastic syndromes: results from the phase III IMerge studyMikkael A Sekeres, Amer M Zeidan, Valeria Santini, et al.
British Journal of Haematology|June 17, 2025
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studiesMichael R Savona, Olatoyosi Odenike, Gail J Roboz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid LeukemiaHaley E Ramsey, Dalton Greenwood, Susu Zhang, et al.
Blood Cancer Journal|January 15, 2024
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation riskAshwin Kishtagari, M A Wasay Khan, Yajing Li, et al.
Blood Advances|February 12, 2020
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignanciesMelissa A Fischer, Sharon Y Friedlander, Maria P Arrate, et al.
Immunohorizons|December 22, 2022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-TalkDalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, et al.
Cancer Research|January 29, 2024
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid LeukemiaAndrew J Monteith, Haley E Ramsey, Alexander J Silver, et al.
Blood Advances|March 20, 2024
Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activationJ Brett Heimlich, Pawan Bhat, Alyssa C Parker, et al.
Blood Advances|April 14, 2022
Patient-specific comorbidities as prognostic variables for survival in myelofibrosisAndrew L Sochacki, Cosmin Adrian Bejan, Shilin Zhao, et al.
Pageof 16